CSL is now calling for applications for the first two inaugural fellowships under the recently announced $25 million program for early stage and translational research in Australia.
Two five-year fellowships are to be awarded each calendar year for ten years. The total value of each award is $1.25 million, paid in annual instalments of A$250,000 to the employing university or medical research institute.
"The CSL Centenary Fellowships are high-value, long-term, competitively-selected grants available to outstanding Australian researchers seeking to consolidate their career and undertake medical research in an Australian academic institution," said the company in a statement.
CSL said it is expected that each fellowship will provide for a full-time salary plus research costs and/or a research assistant. Applicants must be mid-career Australian citizens (or permanent residents) working in early stage and translational research. Preference is expressed for a focus on rare and serious diseases, immunology, or inflammation.
“We believe Australia’s medical research community is world-class and a rich source of potential discoveries to address the world’s unmet medical needs. We hope that the recipients of these fellowships will one day help to broaden the pool of life-saving, life changing medicines,” said Dr Andrew Cuthbertson, CSL Chief Scientific Officer and Director of Research & Development.
Applications for the first two CSL Centenary Fellowships are open as of 1 June 2016 and will close on 31 July 2016. Successful applicants will be announced on 30 September. Further information is available at the CSL fellowship website.